Vyne Therapeutics Inc
NASDAQ:YARW
Vyne Therapeutics Inc
NASDAQ:YARW
Price:
26.07
USD
-6.49%
Market Closed
Market Cap:
$870.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Vyne Therapeutics Inc
NASDAQ:YARW
|
US |
|
Bank Polska Kasa Opieki SA
F:BP1
|
PL |
|
RMB Holdings Ltd
F:R8B
|
ZA |
|
B
|
Broadridge Financial Solutions Inc
LSE:0HPW
|
US |
|
Eutelsat Communications SA
OTC:ETCMY
|
FR |
|
Tokyu Fudosan Holdings Corp
OTC:TTUUF
|
JP |
|
H
|
Hikma Pharmaceuticals PLC
SWB:H5P
|
UK |
|
C
|
Castleview Property Fund Ltd
JSE:CVW
|
ZA |
|
N
|
Nebius Group NV
SWB:YDX
|
NL |
|
P
|
Peruvian Metals Corp
OTC:DUVNF
|
CA |
Multiples-Based Value
The Multiples-Based Value for Vyne Therapeutics Inc (YARW) under the Base Case is hidden
USD.
Compared with the current market price of 26.07 USD, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
YARW Multiples-Based Value
LOCKED